Poster Presentations

1. Gupta, R., Nguyen, D., Schaid, M.D., Kimple, M.E., and Bhatnagar, S. A Gene Expression Network Analysis of the Pancreatic Islets from Lean and Obese Mice Identifies Complement 1q-Like-3 Secreted Protein as a Regulator of Beta-Cell Function. American Diabetes Association’s 79th Scientific Sessions, in San Francisco, CA, June 7–11, 2019. 
2. Gupta, R., Nguyen, D., Schaid, M.D., Kimple, M.E., and Bhatnagar, S.  A Secreted Protein Complement 1q Like-3 Protein Inhibits Insulin Secretion by an Adhesion G-Protein Coupled Receptor, BAI3 in Pancreatic ß-Cells. Endocrine Society, New Orleans, LA, March 23–25, 2019.  (Selected for Presidential Poster Competition)
3. Gupta, R., Schaid, M., Kimple, M., Koltes, J.E., Bhatnagar, S. The complement-1q-like-3 inhibits insulin secretion by an adhesion G-protein coupled receptor, BAI3 in pancreatic beta cells. 78th American Diabetes Association Scientific Sessions, Orlando, FL, June, 2018. 
4. Huynh, T.C.,Gupta R., and Bhatnagar, S. Early phase insulin secretion regulated by tomosyn abundance via synaptotagmin-9. Darwin Day UAB, Birmingham, AL, February 8, 2018. 
5. Huynh, T.C., Gupta, R., and Bhatnagar, S. Synaptotagmin-9 regulates tomosyn protein abundance to affect early phase of insulin secretion. Southeastern Medical Scientist Symposium; Atlanta, GA, November 18–19, 2017. 
6. Gupta, R., Huynh, T.C., Truong, C., and Bhatnagar, S. Synaptotagmin-9 Regulates Tomosyn-2 Protein Abundance to Affect Early Phase of Insulin Secretion. American Diabetes Association Conference: 77nd Scientific Sessions, San Diego, CA, June 9-13, 2017
7. Koltes, J., Gupta, R., Bhatnagar, S. Transcriptomics, informatics and functional analyses identify the secreted protein C1ql3 as a regulator of pancreatic beta-cell function. Keystone Symposia: Obesity and Type 2 Diabetes, Keystone, CO, January 22-27, 2017.
8. Wrighton, L., Bhatnagar, S., Keller, M.P., Chapman, E., Attie, A.D. Sytmaptotagmin-11 is required for the formation of the dense core in insulin granules. Midwest Islet Conference, Chicago, May 20th-21st, 2015.
9. Bhatnagar, S., Schneider, L.R., Hebert, A., Coon, J.J., Attie, A.D.  Insulin, cAMP, and phorbol ester-activated cell signaling pathways phosphorylate tomosyn-2 to regulate insulin secretion in pancreatic beta-cells. American Diabetes Association Conference: 73nd Scientific Sessions, Chicago, IL; June 21-25, 2013.
10. Bhatnagar, S., Schneider, L.R., Hebert, A., Soni, M.S., Keller, M.P., Coon, J.J., Attie, A.D. Glucose, cAMP, and phorbol ester-activated cell signaling pathways phosphorylate tomosyn-2 to regulate insulin secretion in pancreatic beta-cells. Complex Trait Community 12th Annual Meeting, University of Wisconsin-Madison, Madison, WI; May 28-31, 2013.
11. Soni, M.S, Keller, M.P., Rabaglia, M.E., Bhatnagar, S., Shang, J., Li, J., Zhou, H., Zhou, Y.P., Kheterpal, I., Mynatt, R., Newgard, C.B., Howard, A.D., and Attie, A.D. MiRNAs 132 and 212 Result in a Down-Regulation of CACT, Leading to an Increase in Insulin Secretion Via Fatty Acyl-Carnitine Accumulation. The Midwest Islet Club Conference, University of Michigan, Ann Harbor, MI; May 22–23, 2013.
12. Soni, M.S., Keller, M.P., Rabaglia, M.E., Bhatnagar, S., Shang, J., Zhou, Y.P., Mynatt, R., and Attie, A.D. MiRNAs 132 and 212 result in a down-regulation of CACT, leading to an increase in insulin secretion via accumulation of fatty acyl-carnitine molecules. Keystone Symposia: Diabetes - New Insights into Mechanism of Disease and its Treatment (J6), Keystone, CO; January 27 - February 1, 2013.
13. Bhatnagar, S., Schneider, L.R., Hebert, A., Coon, J.J., Attie, A.D.  Insulin, cAMP, and phorbol ester-activated cell signaling pathways phosphorylate tomosyn-2 to regulate insulin secretion in pancreatic beta-cells. Keystone Symposia: Diabetes - New Insights into Mechanism of Disease and its Treatment (J6), Keystone, CO; January 27 - February 1, 2013.
14. Bhatnagar, S., Hebert, A., Oler, A.T., Rabaglia, M.E., Schneider, L.R., Stapleton, D.S., Schueler, K.L., Keller, M.P., Coon, J.J., Attie, A.D. An E3-ubiquitin ligase regulates the activity of an inhibitor of insulin secretion. American Diabetes Association Conference: 72nd Scientific Sessions Pennsylvania Convention Center, Philadelphia, PA; June 8-12, 2012.
15. Bhatnagar, S., Oler, A.T., Rabaglia, M.R., Stapleton, D.S., Keller, M., Schueler, K.L., Attie, A.D. Positional cloning of a type 2 diabetes quantitative trait locus; Tomosyn-2, a negative regulator of insulin secretion. Keystone Symposia: Pathogenesis of Diabetes: Emerging Insights into Molecular Mechanisms (J8), Santa Fe, NM; Jan 29–Feb 3, 2012.
16. Bhatnagar, S., Oler, A.T., Rabaglia, M.R., Stapleton, D.S., Keller, M., Schueler, K.L., Attie, A.D. Positional cloning of a type 2 diabetes quantitative trait locus; Tomosyn-2, a negative regulator of insulin secretion. The Metabolism of Lipids: Implication in Human Diseases, 34th Steenbock Symposium, Madison, WI; May 22–25, 2011.
17. Bhatnagar, S., Oler, A.T., Rabaglia, M.R., Stapleton, D.S., Keller, M., Schueler, K.L., Attie, A.D. Positional cloning of a type 2 diabetes quantitative trait locus; Tomosyn-2, a negative regulator of insulin secretion. The Midwest Islet Club Conference, University of Wisconsin-Madison, Madison, WI; May 25–27, 2011.
18. Bhatnagar, S., Oler, A.T., Rabaglia, M.R., Stapleton, D.S., Keller, M., Schueler, K.L., Attie, A.D. The role of tomosyn-2 in insulin secretion. The Midwest Islet Club Conference, Indiana University School of Medicine, Indianapolis, IN; May 26–27, 2010.
19. Oler, A.T., Bhatnagar, S., Rabaglia, M.R., Stapleton, D.S., Keller, M., Schueler, K.L., Fusilier, A.M., Attie, A.D. Defective insulin secretion attributed to a diabetes susceptibility locus on mouse chromosome 16. The Midwest Islet Club Conference, St Louis, MO; May 27–29, 2009.
20. Bhatnagar, S., Hillgartner, F.B. Fibroblast Growth Factor-19: A Novel Factor for Inhibiting Fatty Acid Synthesis. FASEB Summer Conferences: Molecular Mechanisms Involved in the Nutrient Control of Cellular Function, Carefree, Arizona; July 20–25, 2008.
21. Bhatnagar, S., Hillgartner, F.B. Fibroblast Growth Factor-19 Inhibits Fatty Acid Synthesis in Hepatocytes in Culture. Keystone symposia: Diabetes Mellitus, Insulin Action and Resistance (A6), Breckenridge, CO; January 22–27, 2008.
22. Bhatnagar, S., Hillgartner, F.B. Fibroblast Growth Factor-19 Inhibits Fatty Acid Synthesis in Hepatocytes in Culture. Nuclear Receptors in Liver and Digestive Diseases: A Research Workshop, Rockville, MD; November 7–8, 2007.
23. Bhatnagar, S., Hillgartner, F.B. Fibroblast Growth Factor-19 Inhibits Fatty Acid Synthesis in Hepatocytes in Culture.  E.J. Van Liere Research Convocation and Research Day, West Virginia University, WV; 2007.
24. Srivastava, A., Prakash, N.T., Bhatnagar, S., Kumar, A., Gupta, U., Sadana, J. Selenium Toxicity in Waters, Soils and Crops in Nawashahar Region of India. 8th International Symposium on Selenium in Biology and Medicine, Selenium, University of Wisconsin, Madison, WI; July 25–30, 2006.​
25. Bhatnagar, S., Hillgartner, F.B. Fibroblast Growth Factor-19 Inhibits the Actions of Insulin, Thyroid Hormone, and Liver X Receptor Agonists on Lipogenic Gene Expression in Liver. E.J. Van Liere Research Convocation and Research Day, West Virginia University, WV; 2006.